| Статус: | Recruiting |
| Фаза: | Phase 4 |
| Начало: | 13 января 2025 г. |
| Окончание: | 31 декабря 2027 г. |
| Описание: | Study is to evaluate the efficacy of the drug Ranquilon, 1 mg tablets, at a dosage of 6 mg/day compared to the drug Afobazole, 10 mg tablets, at a dosage of 30 mg/day for the treatment of patients with anxiety disorders due to neurasthenia and adaptation disorders. |
| смотреть на ClinicalTrials.gov |